Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[haysaw]

I think the whole idea is ludicrous: The 'letter' being a positive, or 'intentionally' planned (ie, silver lining); the FDA feeling pressured from public outrage, and backing down; the FDA retreating after being 'bombarded' with safety data; and the exaggeration of the demand and benefits behind the product. I don't think the FDA are pushovers, particularly with small players.

Hopefully there is a silver lining, but it won't be because of this.